Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
UKConference

Superbugs & Superdrugs 2018

Tackling the scientific, regulatory and economic challenges, in order to combat anti-microbial resistance

Add this event to your calendar: iCal   Google Calendar

Details

Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018.

The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders, drug discovery specialists and government bodies such as MHRA and DNDi.

FEATURED SPEAKERS INCLUDE:

  • Richard Bax, Senior Partner, TranScrip Partners
  • Lloyd Czaplewski, Director, Chemical Biology Ventures
  • Mair Powell, Senior clinical assessor, MHRA
  • Jean-Pierre Paccaud, Director of Business Development at GARDP, Drugs for Neglected Diseases initiative (DNDi)
  • Conrad Lichtenstein, CSO, Nemesis bioscience
  • David Brown, Managing Director and Founder, Alchemy Biomedical Consulting
  • Domingo Gargallo-Viola, Chief Scientific Officer, ABAC Therapeutics
  • John George, CSO, Oppilotech
  • Larry Sutton, Scientific Founder, Gladius Pharmaceuticals
  • Kathy Talkington, Project Director, Pew charitable trusts
  • David Cook, Chief Scientific Officer, Blueberry Therapeutics
  • William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center
  • Cara Cassino, Chief Medical Officer, ContraFect
  • Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS Inc

WHATS ON THE AGENDA FOR 2018?

  • Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR
  • Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress
  • Learn about regulatory pathways for the registration of new antimicrobial agents
  • Evaluate the latest incentives and funding solutions to spur drug discovery
  • Explore novel alternatives to antibiotics currently in development

To register visit www.superbugssuperdrugs.com

For enquires contact the team on +44 (0)207 827 6000 or email events@smi-online.co.uk

Contact

Teri Arri
tarri@smi-online.co.uk

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.